Intergalactic Therapeutics
150 Cambridgepark Dr
Cambridge
MA
02140
United States
6 articles about Intergalactic Therapeutics
-
Intergalactic Therapeutics Announces Positive Results for Its Non-Viral Gene Therapy Platform in ABCA4 Retinopathies in Non-Human Primates
6/27/2023
Intergalactic Therapeutics today announced positive preclinical data from IG-002, its lead program addressing all forms of ABCA4-related retinopathies.
-
Intergalactic Therapeutics to Host Virtual KOL Investor Event on May 23, 2023
5/16/2023
Intergalactic Therapeutics announced today that it will host a virtual investor event with scientific experts in the fields of ophthalmology, bioengineering, and gene therapy on Tuesday, May 23, 2023 at 10:00 a.m. ET.
-
Intergalactic Therapeutics to Present Preclinical Data Highlighting Potential of Its Non-Viral Gene Therapy Platform at the American Society of Gene and Cell Therapy 26th Annual Meeting
5/11/2023
Intergalactic Therapeutics announced today that it will present two posters highlighting preclinical data for IG-002, Intergalactic's lead program addressing all forms of ABCA4-related retinopathies, at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, being held in Los Angeles, CA, from May 16-20, 2023.
-
Intergalactic Therapeutics Announces Positive Preclinical Results of Its Non-Viral Gene Therapy Platform in ABCA4 Retinopathies
3/15/2023
Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today positive preclinical results from its lead program IG-002 addressing all forms of ABCA4-related retinopathies.
-
Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer
1/6/2023
Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced the appointment of Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer.
-
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.